Rapamycin-eluting stents for the treatment of unprotected left main coronary disease

American Heart Journal

Volumn 148, Issue 3, 2004, Pages 481-485

  De Lezo, Jose Suarez ^a,c   Medina, Alfonso ^b   Pan, Manuel ^a   Delgado, Antonio ^b   Segura, José ^a   Pavlovic, Djordje ^a   Melián, Francisco ^b   Romero, Miguel ^a   Burgos, Luis ^b   Hernández, Enrique ^b   Ureña, Isabel ^a   Herrador, Juan ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; IMPLANTATION; INTRAVASCULAR ULTRASOUND; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; Q WAVE; QUANTITATIVE ANALYSIS; RESTENOSIS; REVASCULARIZATION; SAFETY; STENOSIS; THROMBOSIS; TIME SERIES ANALYSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SIROLIMUS; STENTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 4644335241     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.03.011     Document Type: Article

References (21)

1. Caracciolo E.A., Davis K.B., Sopko G., et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease long-term CASS experience. Circulation. 91:1995;2325-2334
2. Ferreira A.C., Peter A.A., Salerno T.A., et al. Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary case center. Ann Thorac Surg. 75:2003;485-489
3. Park S.J., Park S.W., Hong M.K., et al. Stenting of unprotected left main coronary artery stenoses immediate and late outcomes. J Am Coll Cardiol. 31:1998;37-42
4. Laruelle C.J., Brueren G.B., Ernst S.M., et al. Stenting of "unprotected" left main coronary artery stenoses early and late results. Heart. 79:1998;148-152
5. Hong M.K., Park S.W., Lee C.W., et al. Intravascular ultrasound findings in stenting of unprotected left main coronary artery stenosis. Am J Cardiol. 82:1998;670-673
6. Silvestri M., Barragan P., Sainsous J., et al. Unprotected left main coronary artery stenting immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol. 35:2000;1543-1550
7. Suárez de Lezo J., Medina A., Romero M., et al. Predictors of restenosis following unprotected left main coronary stenting. Am J Cardiol. 88:2001;308-310
8. Pan M., Suárez de Lezo J., Medina A., et al. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am J Cardiol. 83:1999;1320-1325
9. Pan M., Suárez de Lezo J., Medina A., et al. A stepwise strategy for the stent treatment of bifurcated coronary lesions. Cathet Cardiovasc Intervent. 55:2002;50-57
10. Suárez de Lezo J., Pan M., Medina A., et al. Percutaneous cardiopulmonary support in critical patients needing coronary interventions with stents. Cathet Cardiovasc Intervent. 57:2002;467-475
11. Morice M.C., Serruys P.W., Sousa J.E., et al. Randomized study with the Sirolimus-coated Bx Velocity balloon expandable stent in the treatment of patients with de novo native coronary artery lesions a randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization. N Engl J Med. 346:2002;1773-1780
12. Serruys P.W., Degertekin M., Tanabe K., et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL trial. Circulation. 106:2002;798-803
13. Degertekin M., Serruys P.W., Foley D.P., et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation long term (up to 2 years) clinical, angiographic and intravascular ultrasound follow-up. Circulation. 106:2002;1610-1613
14. Hong M.K., Mintz G.S., Lee C.W., et al. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation. 107:2003;517-520
15. Sousa J.E., Costa M.A., Sousa A.G., et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation. 107:2003;381-383
16. Sousa J.E., Costa M.A., Abizaid A., et al. Sirolimus-eluting stent for the treatment of in-stent restenosis a quantitative coronary angiography and three-dimensional intravascular ultrasound studies. Circulation. 107:2003;24-27
17. Degertekin M., Regar E., Tanabe K., et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis the first clinical experience. J Am Coll Cardiol. 41:2003;184-189
18. Tanabe K., Serruys P.W., Grube E., et al. TAXUS III Trial in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation. 107:2003;559-564
19. Arampatzis C.A., Lemos P.A., Tanabe K., et al. Effectiveness of sirolimus-eluting stent for the treatment of left main coronary artery disease. Am J Cardiol. 92:2003;327-329
20. Suárez de Lezo J., Medina A., Pan M., et al. Sirolimus-eluting stents for the treatment of unprotected left main coronary lesions. [abstract] Eur Heart J. 24:2003;83
21. Costa M.A., Sabaté M., van der Giessen W.J., et al. Late coronary occlusion after intracoronary brachytherapy. Circulation. 100:1999;789-792